Filter by
Filter by
Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.
Published in the Green Journal, this multicenter study reported 62 brain tumor adult patients neurocognitive function after PBT. For two years of followup time...
Proton beam therapy utilization in adults with primary brain tumors in the United States.
Based on the National Cancer Database, a total of 1,296 patients received PBT from 2004 and 2015 for treatment of their primary brain tumor. High-grade glioma...
Late contrast enhancing brain lesions in proton treated low-grade glioma patients: clinical evidence for increased periventricular sensitivity and variable RBE.
Late radiation-induced contrast enhancing brain lesions (CEBL) on MR images after proton therapy of brain tumors have been observed to occur frequently in...
Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons.
This is a randomized phase II trial compared the radiation-induced grade 3+ lymphopenia (G3+L), which was defined as an absolute lymphocyte count (ALC) nadir of...
Lower doses to hippocampi and other brain structures for skull-base meningiomas with IMPT compared to photon therapy.
This study systematically compared intensity modulated proton therapy (IMPT), non-coplanar volumetric modulated arc therapy (VMAT) and intensity modulated...
Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system?
A review article published in the Green Journal. Having analyzed the available data of PBT for paediatric cancers of the central nervous system (CNS), this...
National practice patterns of proton vs photon therapy in the treatment of adult patients with primary brain tumors in the US.
With National Cancer Database, 73,073 adult patients with primary brain tumors treated with radiation were analyzed (n = 72,635 [99.4%] photon therapy, n = 438...